Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition

American Journal of Physiology - Renal Physiology

Volumn 281, Issue 1 50-1, 2001, Pages

  Quiroz, Yasmir ^a   Pons, Héctor ^a   Gordon, Katherine L ^b   Rincón, Jaimar ^a   Chávez, Maribel ^a   Parra, Gustavo ^a   Herrera Acosta, Jaime ^c   Gómez Garre, Dulcenombre ^d   Largo, Raquel ^d   Egido, Jesus ^d   Johnson, Richard J ^b   Rodríguez Iturbe, Bernardo ^a,e  

^a HOSPITAL UNIVERSITARIO DE MARACAIBO   (Venezuela)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^e NONE   (Venezuela)

Author keywords

Angiotensin II positive cells; Lymphocytes; Nitric oxide inhibition

Indexed keywords

ANGIOTENSIN; DRINKING WATER; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BLOOD PRESSURE REGULATION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HYPERTENSION; INHIBITION KINETICS; KIDNEY DISEASE; KIDNEY INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SALT INTAKE; T LYMPHOCYTE ACTIVATION;

EID: 0034809074     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.281.1.f38     Document Type: Article

References (41)

1. Mycophenolate mofetil and its mechanism of action
2. Mycophenolate mofetil reduces myofibroblast infiltration and collagen III deposition in rat remnant kidney
3. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage
4. Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: Role of endothelin
5. Angiotensin I-converting enzyme in human circulating mononuclear cells: Generic polymorphism of expression in T lymphocytes
6. Evidence that the autonomic nervous system plays a major role in the L-NAME-induced hypertension in conscious rats
7. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
8. Mycophenolate mofetil attenuates renal injury in the rat remnant kidney
9. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition
10. The renal origin of hypertension
11. Nitric oxide and the depressor response to angiotensin blockade in hypertension
12. Regulation of angiotensin II type I receptor mRNA and protein in angiotensin II-induced hypertension
13. Effect of mycophenolate mofetil on TNF alpha-induced expression of cell adhesion molecules in human venous endothelial cells in vitro
14. Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion
15. Renal injury and salt-sensitive hypertension after exposure to catecholamines
16. Hypothesis: Is essential hypertension an acquired tubulointerstitial renal disease?
17. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade
18. Post-cyclosporin-mediated hypertension and nehropathy: Amelioration by vascular endothelial growth factor
19. Locally activated renin-angiotensin system associated with TGF-β1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats
20. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats
21. Upregulation of osteopontin expression by ischemia in rat kidneys
22. Angiotensin converting enzyme (kininase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines
23. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion
24. Salt-sensitive hypertension develops after short-term exposure to angiotensin II
25. Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats
26. Glomerular proliferative activity and T lymphocyte infiltration in acute serum sickness
27. Pathogenesis of cyclosporine nephropathy: Roles of angiotensin II and osteopontin
28. Mesangial immune injury, hypertension and progressive damage in Dahl rats
29. Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals
30. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension
31. Comparison of the T lymphocyte-dependent induction of angiotensin-converting enzyme and leucine aminopeptidase in cultured human monocytes
32. Cyclosporine A reduces the expression of adhesion molecules in the kidney of rats with chronic serum sickness
33. Mycophenolate mofetil prevents the progressive renal failure induced by 5/6 renal ablation in rats
34. Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit
35. Sympatheticallymediated hypertension caused by chronic inhibition of nitric oxide
36. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants
37. Early induction of transforming growth factorbeta via angiotensin II receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats
38. Important role of local angiotensin II activity mediated via type 1 receptor in the pathogenesis of cardiovascular inflammatory changes induced by chronic blockade of nitric oxide synthesis in rats
39. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthesis inhibition
40. Granuloma macrophages in immune Schistosomiasis mansoni generate components of the angiotensin system
41. Chronic nitric oxide inhibition model six years on